Code | 36528 | ||||||||||
MA number | 31/0409/06-S | ||||||||||
Product Form: | tbl 30x40 mg | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | National | ||||||||||
MAH, country: | MEDOCHEMIE Ltd., Cyprus | ||||||||||
Therapeutic Class: | 31 - HYPOLIPIDAEMICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | blister Al/PVC | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 19.09.2006 |
Pediatric warnings: | Yes |
SPC: | SPC_MEDOSTATIN 40 mg_10/2020.docx |
PIL: | PIL_MEDOSTATIN 40 mg_10/2020.docx |
Safety feature | Yes |
Data update: | 29.10.2020 |